BCIM
PPH icon

British Columbia Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

British Columbia Investment Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.6M Sell
545,207
-143,404
-21% -$15.3M 0.33% 54
2025
Q4 		$71M Buy
+688,611
New +$67M 0.37% 47

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

British Columbia Investment Management's PPH Position: Q1 2026 in Review

British Columbia Investment Management reduced its VanEck Pharmaceutical ETF (PPH) stake by 21% in Q1 2026, selling an estimated $15.3M and leaving 545,207 shares worth $56.6M. The position accounts for 0.33% of the portfolio, ranked #54.

British Columbia Investment Management first reported a position in PPH in Q4 2025 and has held it in 2 quarters since. The position peaked at $71M in Q4 2025. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • British Columbia Investment Management held 545,207 shares of VanEck Pharmaceutical ETF worth $56.6M as of Q1 2026.
  • British Columbia Investment Management sold 143,404 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $15.3M.
  • VanEck Pharmaceutical ETF made up 0.33% of British Columbia Investment Management's portfolio in Q1 2026, its #54 holding.
  • British Columbia Investment Management first reported a position in VanEck Pharmaceutical ETF in Q4 2025 and has held it in 2 quarters since.
  • British Columbia Investment Management's VanEck Pharmaceutical ETF position peaked at $71M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.